These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 18386616)

  • 21. Prediction of thrombotic and hemorrhagic events during polycythemia vera or essential thrombocythemia based on leukocyte burden.
    Lim Y; Lee JO; Kim SH; Kim JW; Kim YJ; Lee KW; Lee JS; Bang SM
    Thromb Res; 2015 May; 135(5):846-51. PubMed ID: 25743883
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutation of the prothrombin gene and thrombotic events in patients with polycythemia vera or essential thrombocythemia: a cohort study.
    Gisslinger H; Müllner M; Pabinger I; Heis-Vahidi-Fard N; Gisslinger B; Brichta A; Bachleitner-Hofmann T; Mannhalter C
    Haematologica; 2005 Mar; 90(3):408-10. PubMed ID: 15749677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thrombosis and bleeding in polycythemia vera and essential thrombocythemia: pathogenetic mechanisms and prevention.
    Landolfi R; Cipriani MC; Novarese L
    Best Pract Res Clin Haematol; 2006; 19(3):617-33. PubMed ID: 16781491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Annual Clinical Updates in Hematological Malignancies: a continuing medical education series: polycythemia vera and essential thrombocythemia: 2011 update on diagnosis, risk-stratification, and management.
    Tefferi A
    Am J Hematol; 2011 Mar; 86(3):292-301. PubMed ID: 21351120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of arterial thrombotic events in inflammatory bowel disease.
    Ha C; Magowan S; Accortt NA; Chen J; Stone CD
    Am J Gastroenterol; 2009 Jun; 104(6):1445-51. PubMed ID: 19491858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk-adapted therapy in essential thrombocythemia and polycythemia vera.
    Finazzi G; Barbui T
    Blood Rev; 2005 Sep; 19(5):243-52. PubMed ID: 15963833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A prospective analysis of thrombotic events in the European collaboration study on low-dose aspirin in polycythemia (ECLAP).
    Finazzi G;
    Pathol Biol (Paris); 2004 Jun; 52(5):285-8. PubMed ID: 15217715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myocardial infarction as a thrombotic complication of essential thrombocythemia and polycythemia vera.
    Pósfai É; Marton I; Borbényi Z; Nemes A
    Anatol J Cardiol; 2016 Jun; 16(6):397-402. PubMed ID: 27182615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of monoclonal gammopathy and polycythemia vera or essential thrombocythemia: study of a large cohort of patients.
    Randi ML; Tison T; Ruzzon E; Pacquola E; Girolami A
    Ann Hematol; 2003 Apr; 82(4):214-7. PubMed ID: 12707723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leukocytosis and risk stratification assessment in essential thrombocythemia.
    Carobbio A; Antonioli E; Guglielmelli P; Vannucchi AM; Delaini F; Guerini V; Finazzi G; Rambaldi A; Barbui T
    J Clin Oncol; 2008 Jun; 26(16):2732-6. PubMed ID: 18443353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aspirin-responsive painful red, blue, black toe, or finger syndrome in polycythemia vera associated with thrombocythemia.
    Michiels JJ; Berneman Z; Schroyens W; van Urk H
    Ann Hematol; 2003 Mar; 82(3):153-9. PubMed ID: 12634947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic criteria and prognosis in polycythemia vera and essential thrombocythemia.
    Murphy S
    Semin Hematol; 1999 Jan; 36(1 Suppl 2):9-13. PubMed ID: 9930551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expertise-based management in essential thrombocythemia and polycythemia vera.
    Finazzi G; Barbui T
    Cancer J; 2007; 13(6):372-6. PubMed ID: 18032974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aspirin-responsive, migraine-like transient cerebral and ocular ischemic attacks and erythromelalgia in JAK2-positive essential thrombocythemia and polycythemia vera.
    Michiels JJ; Berneman Z; Gadisseur A; Lam KH; De Raeve H; Schroyens W
    Acta Haematol; 2015; 133(1):56-63. PubMed ID: 25116182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Erythromelalgia and vascular complications in polycythemia vera.
    Michiels JJ
    Semin Thromb Hemost; 1997; 23(5):441-54. PubMed ID: 9387203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aspirin for the control of platelet activation and prevention of thrombosis in essential thrombocythemia and polycythemia vera: current insights and rationale for future studies.
    Landolfi R; Di Gennaro L; Novarese L; Patrono C
    Semin Thromb Hemost; 2006 Apr; 32(3):251-9. PubMed ID: 16673279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bilateral adrenal swelling as a cause of chest, back, and upper abdominal pain in essential thrombocythemia and polycythemia vera is due to microvascular ischemic thrombosis rather than to hemorrhage.
    Michiels JJ; Berneman Z; Schroyens W; Krestin GP
    Ann Hematol; 2002 Dec; 81(12):691-4. PubMed ID: 12483364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Venous thromboembolism in patients with essential thrombocythemia and polycythemia vera.
    Reikvam H; Tiu RV
    Leukemia; 2012 Apr; 26(4):563-71. PubMed ID: 22076463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leukocytosis in polycythemia vera and splenomegaly in essential thrombocythemia are independent risk factors for hemorrhage.
    Chou YS; Gau JP; Yu YB; Pai JT; Hsiao LT; Liu JH; Hong YC; Liu CY; Yang CF; Chen PM; Chiou TJ; Tzeng CH
    Eur J Haematol; 2013 Mar; 90(3):228-36. PubMed ID: 23281576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombohemorrhagic events, disease progression, and survival in polycythemia vera and essential thrombocythemia: a retrospective survey in Miyazaki prefecture, Japan.
    Kamiunten A; Shide K; Kameda T; Sekine M; Kubuki Y; Ito M; Toyama T; Kawano N; Marutsuka K; Maeda K; Takeuchi M; Kawano H; Sato S; Ishizaki J; Akizuki K; Tahira Y; Shimoda H; Hidaka T; Yamashita K; Matsuoka H; Shimoda K
    Int J Hematol; 2018 Jun; 107(6):681-688. PubMed ID: 29488167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.